Views & Analysis Digital healthcare round-up: ASCO apps, public health, weara... A round-up of this week's top digital healthcare news. Marco Ricci reports.
Articles Mobile shift in pharma communications Balance engagement and compliance with a non-promotional, patient-centric approach and ongoing development for app success.
Articles Wearables and big data: friends or foes? What benefits can wearable technology bring to healthcare? Dirk Poschenreider asks whether the growing pains and challenges it presents have been fully addressed.
Articles Digital healthcare round-up: digital uptake, machine learnin... A round-up of this week's top digital healthcare news. Marco Ricci reports. Doubts fuelling a lack of excellence in digital healthcare?
Articles Digital healthcare round-up: Fitbit takes aim at medtech, ‘s... A round-up of this week's top digital healthcare news. Marco Ricci reports.
Articles Oncology apps and opportunities for pharma Kevin Bambury examines what apps are being developed, their usefulness, and where there are gaps to fill.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.